On November 5, 2020 Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) reported that the company will arrange a virtual capital markets day for investors, analysts and journalists on November 30th, 2020 (Press release, Oncopeptides, NOV 5, 2020, View Source [SID1234570006]). The program will be published on the company´s website during the week of November 23 at: www.oncopeptides.com/en/calendar/

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oncopeptides Virtual Capital Markets Day
14.00 – 16.00 CET (8:00am-10am ET) November 30th, 2020

The presenters during the Capital Market Day will be:

CEO Marty J Duvall, Oncopeptides,
CSO, Jakob Lindberg, Oncopeptides
CMO Klaas Bakker, Oncopeptides

Professor Paul Richardson, MD, Dana-Farber Cancer Institute, Boston
Associate Professor Maria-Victoria Mateos, MD, PhD, University Hospital, Salamanca
Assistant Professor Joshua Richter, MD, Icahn School of Medicine, Mount Sinai Hospital, New York

The webcast will be accessible at: View Source

The information was submitted for publication at 14.00 CET on November 5, 2020.